Inactive Instrument
Company American Renal Associates Holdings, Inc.
Stocks
ARA
US0292271055
Healthcare Facilities & Services
Business description: American Renal Associates Holdings, Inc.

Sales by Activity: American Renal Associates Holdings, Inc.
| Fiscal Period: December | 2019 (USD) |
|---|---|
The Ownership and Operation of Dialysis Clinics | 823M |
Geographical breakdown of sales: American Renal Associates Holdings, Inc.
| Fiscal Period: December | 2019 (USD) |
|---|---|
United States | 823M |
Executive Committee: American Renal Associates Holdings, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
David Doerr
CEO | Chief Executive Officer | 56 | 01/02/2025 |
Syed Kamal
PSD | President | 73 | 01/01/1999 |
George Attmore
DFI | Director of Finance/CFO | - | - |
Geoffrey Walker
CTO | Chief Tech/Sci/R&D Officer | - | - |
Steve Duke
CTO | Chief Tech/Sci/R&D Officer | - | - |
Company details: American Renal Associates Holdings, Inc.
American Renal Associates Holdings, Inc.
500 Cummings Center
01915, Beverly
+978 922 3080
http://www.innovativerenal.com
Other Healthcare Facilities & Services
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.80% | +4.29% | +31.70% | +47.92% | 124B | ||
| -1.07% | -2.93% | -1.46% | +47.89% | 88.59B | ||
| -0.71% | -4.27% | -4.93% | +50.22% | 28.95B | ||
| -0.93% | -2.20% | +31.82% | +86.59% | 26.42B | ||
| -0.26% | -4.48% | -4.92% | -5.03% | 21.46B | ||
| -0.50% | -1.76% | +36.15% | +242.00% | 21.22B | ||
| -0.99% | +4.49% | -5.15% | +27.25% | 15.97B | ||
| +1.28% | -2.05% | -6.26% | -12.29% | 11.89B | ||
| +0.67% | +0.75% | +34.29% | +88.35% | 11.58B | ||
| Average | -0.35% | -0.87% | +12.36% | +63.65% | 38.93B | |
| Weighted average by Cap. | -0.70% | +0.33% | +15.44% | +57.88% |

















